+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

Metastatic Bone Disease Market Report 2025 - Product Thumbnail Image

Metastatic Bone Disease Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Desmoid Tumors Market Report 2025 - Product Thumbnail Image

Desmoid Tumors Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Laryngeal Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Laryngeal Cancer Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Bone Cancer Treatment Market Report 2025 - Product Thumbnail Image

Bone Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Esophageal Cancer Market Report 2025 - Product Thumbnail Image

Esophageal Cancer Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 287 Pages
  • Global
From
Compounding Chemotherapy - Global Strategic Business Report - Product Thumbnail Image

Compounding Chemotherapy - Global Strategic Business Report

  • Report
  • November 2025
  • 470 Pages
  • Global
From
Laryngeal Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Laryngeal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 273 Pages
  • Global
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 396 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • November 2025
  • 582 Pages
  • Global
From
Nasopharyngeal Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 288 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 102 Pages
  • Global
From
Follicular Thyroid Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Follicular Thyroid Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 278 Pages
  • Global
From
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 371 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 380 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 291 Pages
  • Global
From
From
Gastric Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gastric Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more